ticker,nameOfIssuer,cusip,value,shares,allocation_percent,filingDate,reportDate,accessionNumber
2L9,BLUEPRINT MEDICINES CORP,09627Y109,47657000.0,2640251,11.792813502953338,2016-05-16,2016-03-31,0000921895-16-004561
CNCEEUR,CONCERT PHARMACEUTICALS INC,206022105,37638000.0,2755318,9.313593273268518,2016-05-16,2016-03-31,0000921895-16-004561
CYTK,CYTOKINETICS INC,23282W605,30602000.0,4340729,7.572521955166671,2016-05-16,2016-03-31,0000921895-16-004561
N/A,FORWARD PHARMA A/S,34986J105,24502000.0,1441287,6.063065582167629,2016-05-16,2016-03-31,0000921895-16-004561
N/A,ONCOTHYREON INC,682324108,23875000.0,18799368,5.907913263172481,2016-05-16,2016-03-31,0000921895-16-004561
N/A,CTI BIOPHARMA CORP,12648L106,23805000.0,44796940,5.890591632662656,2016-05-16,2016-03-31,0000921895-16-004561
ARRYEUR,ARRAY BIOPHARMA INC,04269X105,23158000.0,7850211,5.730490276378988,2016-05-16,2016-03-31,0000921895-16-004561
EXEL 4.25 08/15/19,EXELIXIS INC,30161QAC8,22723000.0,22822778,5.622848715353646,2016-05-16,2016-03-31,0000921895-16-004561
CCXIEUR,CHEMOCENTRYX INC,16383L106,20373000.0,8182052,5.041336833952376,2016-05-16,2016-03-31,0000921895-16-004561
IRWD,IRONWOOD PHARMACEUTICALS INC,46333X108,19208000.0,1755745,4.753055411896002,2016-05-16,2016-03-31,0000921895-16-004561
N/A,VITAE PHARMACEUTICALS INC,92847N103,13850000.0,2089014,3.4272083223011043,2016-05-16,2016-03-31,0000921895-16-004561
N/A,ONCOMED PHARMACEUTICALS INC,68234X102,13541000.0,1339336,3.350745696193448,2016-05-16,2016-03-31,0000921895-16-004561
ARQLUSD,ARQULE INC,04269E107,12629000.0,7893324,3.12506959583687,2016-05-16,2016-03-31,0000921895-16-004561
XENE,XENON PHARMACEUTICALS INC,98420N105,12411000.0,1775572,3.071125089391986,2016-05-16,2016-03-31,0000921895-16-004561
N/A,QLT INC,746927102,11346000.0,5701609,2.8075888537782188,2016-05-16,2016-03-31,0000921895-16-004561
ESPR,ESPERION THERAPEUTICS INC NE,29664W105,10261000.0,606801,2.5391035808759304,2016-05-16,2016-03-31,0000921895-16-004561
N/A,TOBIRA THERAPEUTICS INC,88883P101,10253000.0,1253401,2.5371239659605216,2016-05-16,2016-03-31,0000921895-16-004561
N/A,CELATOR PHARMACEUTICALS INC,15089R102,8824000.0,800000,2.183515251695664,2016-05-16,2016-03-31,0000921895-16-004561
CTMX,CYTOMX THERAPEUTICS INC,23284F105,7819000.0,606138,1.9348261279474608,2016-05-16,2016-03-31,0000921895-16-004561
N/A,NIVALIS THERAPEUTICS INC,65481J109,6450000.0,1546743,1.5960645255481676,2016-05-16,2016-03-31,0000921895-16-004561
N/A,GTX INC DEL,40052B108,5756000.0,11512000,1.4243329316364735,2016-05-16,2016-03-31,0000921895-16-004561
N/A,PAIN THERAPEUTICS INC,69562K100,4794000.0,2149913,1.1862842380585916,2016-05-16,2016-03-31,0000921895-16-004561
N/A,SUNESIS PHARMACEUTICALS INC,867328601,2599000.0,4813294,0.6431273956433624,2016-05-16,2016-03-31,0000921895-16-004561
N/A,LOXO ONCOLOGY INC,548862101,2047000.0,74870,0.5065339664801705,2016-05-16,2016-03-31,0000921895-16-004561
ARRY 3 06/01/20,ARRAY BIOPHARMA INC,04269XAA3,2025000.0,2500000,0.5010900254627968,2016-05-16,2016-03-31,0000921895-16-004561
N/A,CATALYST BIOSCIENCES INC,14888D109,1631000.0,970948,0.40359399087892434,2016-05-16,2016-03-31,0000921895-16-004561
GBIM,GLOBEIMMUNE INC,37957B100,1355000.0,657653,0.33529727629732825,2016-05-16,2016-03-31,0000921895-16-004561
N/A,MAST THERAPEUTICS INC,576314108,1013000.0,3696961,0.25066873866361145,2016-05-16,2016-03-31,0000921895-16-004561
CALAEUR,CALITHERA BIOSCIENCES INC,13089P101,925000.0,162900,0.22889297459411706,2016-05-16,2016-03-31,0000921895-16-004561
N/A,BIOTA PHARMACEUTIALS INC,090694100,526000.0,350776,0.13015968068811415,2016-05-16,2016-03-31,0000921895-16-004561
N/A,IGNYTA INC,451731103,339000.0,50000,0.08388618204043859,2016-05-16,2016-03-31,0000921895-16-004561
N/A,NEPHROGENEX INC,640667101,184000.0,392156,0.045531143054397344,2016-05-16,2016-03-31,0000921895-16-004561
